ORAMED PHARMACEUTICALS INC. Operating Lease Liability
ORAMED PHARMACEUTICALS INC. (ORMP) had Operating Lease Liability of $733.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $733.00K.
- 2026-03-31: Operating Lease, Liability $761.00K.
- 2025-12-31: Operating Lease, Liability $825.00K.
- 2025-09-30: Operating Lease, Liability $860.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $733.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $761.00K 10-Q · filed 2026-05-19 | |
| 2025-12-31 | $825.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $860.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $912.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $301.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $372.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $429.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $486.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $526.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $609.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $640.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $724.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $806.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $894.00K 10-K · filed 2024-03-06 | |
| 2022-09-30 | $900.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $977.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.11M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $500.00K 10-Q · filed 2022-11-10 | |
| 2021-11-30 | $504.00K 10-Q · filed 2022-01-11 | |
| 2021-08-31 | $533.00K 10-QT · filed 2022-03-30 | $403.00K 10-K · filed 2021-11-24 |
| 2021-05-31 | $560.00K 10-Q · filed 2021-07-14 | |
| 2020-08-31 | $31.00K 10-K · filed 2021-11-24 | |
| 2019-09-02 | $113.00K 10-Q · filed 2020-07-07 | |
| 2019-09-01 | $168.00K 10-Q · filed 2021-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |